Search results
FDA to vote Wednesday on COVID-19 shots to target emerging variants in US for 2024-25
Detroit News· 1 day agoThe Vaccines and Related Biological Products Advisory Committee, which evaluates and recommends ...
New COVID-19 vaccine for fall should target JN.1 lineage, not variant, FDA panel
USA TODAY via Yahoo News· 16 hours agoThe federal advisory group decided on Wednesday the new vaccine should focus on the JN.1 lineage...
Updated Covid-19 Vaccine Targeting JN.1 Recommended By FDA Panel
Forbes· 1 day agoIdeally, these updated vaccines will be available in the fall. The Vaccines and Related Biological ...
FDA panel picks JN.1 subvariant for fall COVID vaccines
The Hill via Yahoo News· 14 hours agoThe expert advisory panel for the Food and Drug Administration (FDA) unanimously voted Wednesday in...
Novavax Says It Can Deliver Recommended Covid Vaccine in September
Morningstar· 14 hours agoBy Ben Glickman Novavax said it expected it would be able to deliver a vaccine targeting the strain of Covid-19 recommended by a regulatory advisory group in the U.S. by September ...
FDA Panel to Consider Which COVID Strain to Target in an Updated Vaccine
MedPage Today· 3 days agoThe current predominant strain of COVID-19 should be a key consideration during the upcoming meeting...
FDA Panel to Consider Updating COVID-19 Jabs for New Virus Strains
Zacks via Yahoo Finance· 2 days agoAn FDA panel meeting is scheduled on Jun 5 to consider if COVID-19 vaccines should be updated to...
FDA panel supports switch to JN.1 for fall COVID vaccines
Center for Infectious Disease Research and Policy· 15 hours agoThe Vaccines and Related Biological Products Advisory Committee (VRBPAC) was originally slated ...
FDA Panel Recommends New COVID Vaccines For JN.1 Lineage By Fall
Forbes· 1 day agoThe FDA’s independent Vaccines and Related Biological Products Advisory Committee voted unanimously...
COVID vaccine makers ready updated shots for fall immunization drive (NYSE:PFE)
Seeking Alpha· 21 hours agoPfizer (PFE), BioNTech (BNTX), Moderna (MRNA) and Novavax (NVAX) reaffirm commitment to provide...